Thalassemia Patients and Friends
Discussion Forums => Iron Chelation Corner => Topic started by: Gabri on May 26, 2007, 05:16:44 PM
-
Deferitrin also named GT56-252, an oral iron chelator passed the Phase III trial.
Does anyone knows somthing more abaut this new drug?
-
Deferitrin, a novel, orally available iron chelator, is in the early stage of clinical development for the treatment of chronic iron overload due to transfusional therapy. Preclinical pharmacology studies demonstrate iron excretion largely by the fecal route. Initial clinical studies have shown deferitrin to be well absorbed. Further clinical studies are ongoing to determine the efficiency and safety of deferitrin.
this is what i found.
ZAINI.
-
Wow! I love this age of oral chelators.
I can't wait to begin using an oral chelator.